The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
AACR 2024: AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma in phase I trial
AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both…